Epitope-based precision immunotherapy of Type 1 diabetes-Reference-Cited by-同舟云学术

Epitope-based precision immunotherapy of Type 1 diabetes

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Firdessa Fite Rebuma¹,Bechi Genzano Camillo¹,Mallone Roberto²³,Creusot Remi J.¹^ORCID

Affiliation:

1. Columbia Center for Translational Immunology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA

2. Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France

3. Assistance Publique Hôpitaux de Paris, Service de Diabétologie et Immunologie Clinique, Cochin Hospital, Hôpitaux Universitaires de Paris Centre-Université de Paris, Paris, France

Funder

NIH

Beatson Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2154098

Reference123 articles.

1. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

2. Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry

3. The NOD Mouse Beyond Autoimmune Diabetes

4. Glycaemic Control in Youth and Young Adults: Challenges and Solutions

5. Glycemic Control and Excess Mortality in Type 1 Diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen-specific T cells and autoimmunity;Journal of Autoimmunity;2024-09

2. Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy;Frontiers in Immunology;2024-06-12

3. FASTMAP—a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells;Frontiers in Immunology;2024-05-08

4. Can type 1 diabetes be prevented or reversed?;Journal of Diabetes;2024-05

5. Application of chimeric antigen receptor-natural killer cells for the treatment of type 1 diabetes;Exploration of Endocrine and Metabolic Disease;2023-11-17